Reviva Pharmaceuticals is a privately held, late-stage clinical development pharmaceutical company that is developing a portfolio of internally discovered therapies that address unmet medical needs in...
RP5063. Schizophrenia. Bipolar Disorder.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company...
Reviva Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and ...
SAN JOSE, CA, USA I March 12, 2012 I Reviva Pharmaceuticals, Inc., a privately held drug
Reviva Pharmaceuticals Reports RP5063 Positive Efficacy Results for Memory Deficits.
Pet Pharmacy - Pet Medications | Revival Animal Health.
rp5063 reviva pharmaceuticals на YouTube: Загрузка... Поисковые системы.
RP-5063, also known as RP-5000, is an investigational atypical antipsychotic which is under development by Reviva Pharmaceuticals for the treatment of schizophrenia and schizoaffective disorder.
1 Revive Pharmaceuticals reviews. A free inside look at company reviews and salaries posted anonymously by employees.